Scientific Reports · 2017 · 34 citations · 47 references
Life SciencesBiotechnologyCell BiologyRegenerative MedicineStem Cell BiologyTissue EngineeringAdipocyte DifferentiationCartilage RegenerationMesenchymal DifferentiationMesenchymal Stem Cell TherapyMesenchymal Stromal Cell TherapyTissue Engineering With Stem CellsBone Marrow - Derived CellsBone Marrow Mesenchymal Stem CellsBone Marrow-derived Mesenchymal Stromal CellsGrowth FactorsMesenchymal Stem Cell ExpansionMesenchymal Stromal Cell CultureMesenchymal Stromal Cell Expansion
Human mesenchymal stromal/stem cells (MSCs) are multipotent and currently undergoing hundreds of clinical trials for disease treatments. To date, no studies have generated induced MSCs from skin fibroblasts with chemicals or growth factors. Here, we established the first chemical method to convert primary human dermal fibroblasts into multipotent, induced MSC-like cells (iMSCs). The conversion method uses a defined cocktail of small molecules and growth factors, and it can achieve efficient conversion with an average rate of 38% in 6 days. The iMSCs have much higher clonogenicity than fibroblasts, and they can be maintained and expanded in regular MSC medium for at least 8 passages and further differentiated into osteoblasts, adipocytes, and chondrocytes. Moreover, the iMSCs can suppress LPS-mediated acute lung injury as effectively as bone marrow-derived mesenchymal stem cells. This finding may greatly benefit stem cell biology, cell therapy, and regenerative medicine.
47
Multilineage Potential of Adult Human Mesenchymal Stem Cells
Mark F. Pittenger, Alastair M. Mackay, Stephen C. Beck et al. · Science · 1999 · 21.1K citations
The ground state of embryonic stem cell self-renewal
Qi‐Long Ying, Jason Wray, Jennifer Nichols et al. · Nature · 2008 · 3.5K citations · Full text